Omnicell (OMCL) Stock Forecast, Price Target & Predictions
OMCL Stock Forecast
Omnicell stock forecast is as follows: an average price target of $78.75 (represents a 94.73% upside from OMCL’s last price of $40.44) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
OMCL Price Target
The average price target for Omnicell (OMCL) is $78.75 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $158.00 to $39.00. This represents a potential 94.73% upside from OMCL's last price of $40.44.
OMCL Analyst Ratings
According to 5 Wall Street analysts, Omnicell's rating consensus is 'Hold'. The analyst rating breakdown for OMCL stock is 0 'Strong Buy' (0.00%), 2 'Buy' (40.00%), 3 'Hold' (60.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Omnicell Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 05, 2024 | Sean Wieland | Piper Sandler | $61.00 | $40.00 | 52.50% | 50.84% |
| Aug 02, 2024 | Stephanie Davis | Barclays | $39.00 | $39.22 | -0.56% | -3.56% |
| Nov 18, 2022 | - | J.P. Morgan | $57.00 | $53.63 | 6.28% | 40.95% |
| Aug 08, 2022 | Jessica Tassan | Piper Sandler | $150.00 | $109.12 | 37.46% | 270.92% |
| Jun 16, 2022 | Stan Berenshteyn | Wells Fargo | $158.00 | $109.82 | 43.87% | 290.70% |
| May 03, 2022 | - | Piper Sandler | $162.00 | $114.90 | 40.99% | 300.59% |
The latest Omnicell stock forecast, released on Aug 05, 2024 by Sean Wieland from Piper Sandler, set a price target of $61.00, which represents a 52.50% increase from the stock price at the time of the forecast ($40.00), and a 50.84% increase from OMCL last price ($40.44).
Omnicell Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 2 |
| Avg Price Target | - | $50.00 | $50.00 |
| Last Closing Price | $40.44 | $40.44 | $40.44 |
| Upside/Downside | -100.00% | 23.64% | 23.64% |
In the current month, the average price target of Omnicell stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Omnicell's last price of $40.44. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 14, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Oct 09, 2024 | Benchmark | Underperform | Underperform | Hold |
| Oct 09, 2024 | Wells Fargo | Buy | Buy | Hold |
| Sep 11, 2024 | KeyBanc | Sector Weight | Sector Weight | Hold |
| Aug 23, 2024 | Wells Fargo | Buy | Buy | Hold |
| Aug 05, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 02, 2024 | Barclays | - | Equal-Weight | Upgrade |
| Nov 02, 2023 | Piper Sandler | - | Overweight | Upgrade |
| Feb 27, 2023 | Benchmark | - | Buy | Upgrade |
| Sep 21, 2022 | BTIG | Buy | Buy | Hold |
Omnicell's last stock rating was published by Wells Fargo on Oct 14, 2024. The company gave OMCL a "Equal-Weight" rating, the same as its previous rate.
Omnicell Financial Forecast
Omnicell Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $258.85M | $298.66M | $298.97M | $290.63M | $297.67M | $348.06M | $331.39M | $318.83M | $311.03M | $296.40M | $272.74M | $251.84M | $249.20M | $213.70M | $199.62M | $229.69M | $248.29M | $228.81M |
| Avg Forecast | $294.29M | $292.00M | $291.28M | $288.36M | $301.84M | $291.82M | $287.07M | $266.04M | $287.85M | $280.45M | $254.41M | $236.77M | $255.52M | $295.47M | $284.52M | $277.65M | $287.16M | $363.23M | $339.45M | $314.36M | $311.08M | $284.74M | $268.57M | $246.72M | $245.69M | $208.88M | $182.42M | $218.99M | $243.69M | $231.86M |
| High Forecast | $294.29M | $292.00M | $291.28M | $288.36M | $301.84M | $291.82M | $287.07M | $266.04M | $287.85M | $283.46M | $254.41M | $236.77M | $258.01M | $296.21M | $284.52M | $277.65M | $287.16M | $363.23M | $339.45M | $314.36M | $311.08M | $284.74M | $268.57M | $246.72M | $245.69M | $208.88M | $182.42M | $218.99M | $243.69M | $231.86M |
| Low Forecast | $294.29M | $292.00M | $291.28M | $288.36M | $301.84M | $291.82M | $287.07M | $266.04M | $287.85M | $278.39M | $254.41M | $236.77M | $252.11M | $293.74M | $284.52M | $277.65M | $287.16M | $363.23M | $339.45M | $314.36M | $311.08M | $284.74M | $268.57M | $246.72M | $245.69M | $208.88M | $182.42M | $218.99M | $243.69M | $231.86M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.01% | 1.05% | 1.05% | 1.04% | 0.96% | 0.98% | 1.01% | 1.00% | 1.04% | 1.02% | 1.02% | 1.01% | 1.02% | 1.09% | 1.05% | 1.02% | 0.99% |
Omnicell's average Quarter revenue forecast for Mar 24 based on 2 analysts is $236.77M, with a low forecast of $236.77M, and a high forecast of $236.77M. OMCL's average Quarter revenue forecast represents a -8.53% decrease compared to the company's last Quarter revenue of $258.85M (Dec 23).
Omnicell EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $72.19M | $3.71M | $31.80M | $1.26M | $-13.74M | $43.20M | $37.87M | $29.52M | $29.83M | $44.48M | $43.24M | $33.39M | $33.88M | $28.62M | $10.39M | $28.05M | $38.65M | $39.82M |
| Avg Forecast | $33.79M | $33.53M | $33.45M | $33.11M | $34.66M | $33.51M | $32.96M | $30.55M | $33.05M | $32.21M | $29.22M | $32.48M | $29.34M | $33.93M | $32.67M | $29.53M | $38.08M | $41.71M | $38.98M | $23.34M | $35.72M | $32.70M | $30.84M | $24.79M | $28.21M | $23.99M | $20.95M | $21.17M | $27.98M | $26.63M |
| High Forecast | $33.79M | $33.53M | $33.45M | $33.11M | $34.66M | $33.51M | $32.96M | $30.55M | $33.05M | $32.55M | $29.22M | $38.98M | $29.63M | $34.01M | $32.67M | $35.44M | $45.69M | $41.71M | $38.98M | $28.01M | $35.72M | $32.70M | $30.84M | $29.75M | $28.21M | $23.99M | $20.95M | $25.41M | $27.98M | $26.63M |
| Low Forecast | $33.79M | $33.53M | $33.45M | $33.11M | $34.66M | $33.51M | $32.96M | $30.55M | $33.05M | $31.97M | $29.22M | $25.99M | $28.95M | $33.73M | $32.67M | $23.62M | $30.46M | $41.71M | $38.98M | $18.68M | $35.72M | $32.70M | $30.84M | $19.83M | $28.21M | $23.99M | $20.95M | $16.94M | $27.98M | $26.63M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.46% | 0.11% | 0.97% | 0.04% | -0.36% | 1.04% | 0.97% | 1.26% | 0.84% | 1.36% | 1.40% | 1.35% | 1.20% | 1.19% | 0.50% | 1.33% | 1.38% | 1.50% |
2 analysts predict OMCL's average Quarter EBITDA for Mar 24 to be $32.48M, with a high of $38.98M and a low of $25.99M. This is -55.00% lower than Omnicell's previous annual EBITDA (Dec 23) of $72.19M.
Omnicell Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-14.38M | $5.55M | $3.45M | $-15.00M | $-28.41M | $16.77M | $9.07M | $8.21M | $13.98M | $29.32M | $20.42M | $14.13M | $16.38M | $8.80M | $-4.30M | $11.31M | $22.09M | $19.98M |
| Avg Forecast | $22.56M | $22.56M | $22.56M | $22.56M | $21.90M | $20.72M | $19.73M | $10.79M | $21.79M | $19.30M | $6.64M | $9.11M | $7.08M | $21.44M | $12.99M | $8.28M | $15.38M | $43.94M | $39.13M | $6.55M | $42.49M | $42.01M | $38.06M | $10.49M | $37.35M | $22.43M | $10.53M | $8.54M | $35.97M | $32.75M |
| High Forecast | $22.56M | $22.56M | $22.56M | $22.56M | $21.90M | $20.72M | $19.73M | $10.79M | $21.79M | $20.24M | $6.65M | $10.93M | $9.17M | $22.35M | $12.99M | $9.94M | $18.45M | $43.94M | $39.13M | $7.86M | $42.49M | $42.01M | $38.06M | $12.59M | $37.35M | $22.43M | $10.53M | $10.24M | $35.97M | $32.75M |
| Low Forecast | $22.56M | $22.56M | $22.56M | $22.56M | $21.90M | $20.72M | $19.73M | $10.79M | $21.79M | $18.83M | $6.64M | $7.29M | $5.00M | $19.16M | $12.99M | $6.63M | $12.30M | $43.94M | $39.13M | $5.24M | $42.49M | $42.01M | $38.06M | $8.39M | $37.35M | $22.43M | $10.53M | $6.83M | $35.97M | $32.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -2.03% | 0.26% | 0.27% | -1.81% | -1.85% | 0.38% | 0.23% | 1.25% | 0.33% | 0.70% | 0.54% | 1.35% | 0.44% | 0.39% | -0.41% | 1.33% | 0.61% | 0.61% |
Omnicell's average Quarter net income forecast for Dec 23 is $7.08M, with a range of $5.00M to $9.17M. OMCL's average Quarter net income forecast represents a 27.57% increase compared to the company's last Quarter net income of $5.55M (Sep 23).
Omnicell SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $101.95M | $103.97M | $103.56M | $125.11M | $131.70M | $115.46M | $119.25M | $119.93M | $115.76M | $97.91M | $89.17M | $86.59M | $87.96M | $71.44M | $69.39M | $78.82M | $82.33M | $70.88M |
| Avg Forecast | $103.51M | $102.70M | $102.45M | $101.42M | $106.16M | $102.64M | $100.97M | $93.57M | $101.24M | $98.64M | $89.48M | $133.03M | $89.87M | $103.92M | $100.07M | $120.93M | $127.33M | $127.75M | $119.39M | $95.60M | $109.41M | $100.15M | $94.46M | $64.29M | $86.41M | $73.47M | $64.16M | $59.49M | $85.71M | $81.55M |
| High Forecast | $103.51M | $102.70M | $102.45M | $101.42M | $106.16M | $102.64M | $100.97M | $93.57M | $101.24M | $99.70M | $89.48M | $159.63M | $90.75M | $104.18M | $100.07M | $145.12M | $152.80M | $127.75M | $119.39M | $114.72M | $109.41M | $100.15M | $94.46M | $77.15M | $86.41M | $73.47M | $64.16M | $71.38M | $85.71M | $81.55M |
| Low Forecast | $103.51M | $102.70M | $102.45M | $101.42M | $106.16M | $102.64M | $100.97M | $93.57M | $101.24M | $97.91M | $89.48M | $106.42M | $88.67M | $103.31M | $100.07M | $96.75M | $101.87M | $127.75M | $119.39M | $76.48M | $109.41M | $100.15M | $94.46M | $51.43M | $86.41M | $73.47M | $64.16M | $47.59M | $85.71M | $81.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 1.00% | 1.03% | 1.03% | 1.03% | 0.90% | 1.00% | 1.25% | 1.06% | 0.98% | 0.94% | 1.35% | 1.02% | 0.97% | 1.08% | 1.33% | 0.96% | 0.87% |
Omnicell's average Quarter SG&A projection for Mar 24 is $133.03M, based on 2 Wall Street analysts, with a range of $106.42M to $159.63M. The forecast indicates a 30.48% rise compared to OMCL last annual SG&A of $101.95M (Dec 23).
Omnicell EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.32 | $0.12 | $0.08 | $-0.33 | $-0.64 | $0.38 | $0.21 | $0.19 | $0.32 | $0.67 | $0.47 | $0.33 | $0.39 | $0.21 | $-0.10 | $0.27 | $0.53 | $0.48 |
| Avg Forecast | $0.49 | $0.49 | $0.49 | $0.49 | $0.48 | $0.45 | $0.43 | $0.23 | $0.47 | $0.42 | $0.14 | $-0.09 | $0.15 | $0.47 | $0.28 | $0.07 | $0.08 | $0.95 | $0.85 | $0.69 | $0.92 | $0.91 | $0.83 | $0.66 | $0.81 | $0.49 | $0.23 | $0.51 | $0.78 | $0.71 |
| High Forecast | $0.49 | $0.49 | $0.49 | $0.49 | $0.48 | $0.45 | $0.43 | $0.23 | $0.47 | $0.44 | $0.14 | $-0.09 | $0.20 | $0.49 | $0.28 | $0.07 | $0.08 | $0.95 | $0.85 | $0.69 | $0.92 | $0.91 | $0.83 | $0.66 | $0.81 | $0.49 | $0.23 | $0.51 | $0.78 | $0.71 |
| Low Forecast | $0.49 | $0.49 | $0.49 | $0.49 | $0.48 | $0.45 | $0.43 | $0.23 | $0.47 | $0.41 | $0.14 | $-0.09 | $0.11 | $0.42 | $0.28 | $0.07 | $0.08 | $0.95 | $0.85 | $0.69 | $0.92 | $0.91 | $0.83 | $0.66 | $0.81 | $0.49 | $0.23 | $0.51 | $0.78 | $0.71 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -2.08% | 0.26% | 0.28% | -4.88% | -7.78% | 0.40% | 0.25% | 0.28% | 0.35% | 0.73% | 0.57% | 0.50% | 0.48% | 0.43% | -0.44% | 0.53% | 0.68% | 0.67% |
According to 4 Wall Street analysts, Omnicell's projected average Quarter EPS for Dec 23 is $0.15, with a low estimate of $0.11 and a high estimate of $0.20. This represents a 28.23% increase compared to OMCL previous annual EPS of $0.12 (Sep 23).
Omnicell Peer Comparison by Price Target
OMCL Forecast FAQ
Is Omnicell a good buy?
No, according to 5 Wall Street analysts, Omnicell (OMCL) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 40.00% of OMCL's total ratings.
What is OMCL's price target?
Omnicell (OMCL) average price target is $78.75 with a range of $39 to $158, implying a 94.73% from its last price of $40.44. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Omnicell stock go up soon?
According to Wall Street analysts' prediction for OMCL stock, the company can go up by 94.73% (from the last price of $40.44 to the average price target of $78.75), up by 290.70% based on the highest stock price target, and down by -3.56% based on the lowest stock price target.
Can Omnicell stock reach $60?
OMCL's average twelve months analyst stock price target of $78.75 supports the claim that Omnicell can reach $60 in the near future.
What are Omnicell's analysts' financial forecasts?
Omnicell's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.15B (high $1.15B, low $1.15B), average EBITDA is $131.69M (high $131.69M, low $131.69M), average net income is $73.13M (high $73.13M, low $73.13M), average SG&A $403.34M (high $403.34M, low $403.34M), and average EPS is $1.59 (high $1.59, low $1.59). OMCL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.17B (high $1.17B, low $1.17B), average EBITDA is $133.89M (high $133.89M, low $133.89M), average net income is $90.23M (high $90.23M, low $90.23M), average SG&A $410.08M (high $410.08M, low $410.08M), and average EPS is $1.96 (high $1.96, low $1.96).
Did the OMCL's actual financial results beat the analysts' financial forecasts?
Based on Omnicell's last annual report (Dec 2023), the company's revenue was $1.15B, beating the average analysts forecast of $1.11B by 3.05%. Apple's EBITDA was $60.69M, missing the average prediction of $125.48M by -51.63%. The company's net income was $-20.371M, missing the average estimation of $49.8M by -140.91%. Apple's SG&A was $434.59M, beating the average forecast of $414.8M by 4.77%. Lastly, the company's EPS was $-0.45, missing the average prediction of $0.969 by -146.42%. In terms of the last quarterly report (Dec 2023), Omnicell's revenue was $258.85M, beating the average analysts' forecast of $255.52M by 1.30%. The company's EBITDA was $72.19M, beating the average prediction of $29.34M by 146.04%. Omnicell's net income was $-14.375M, missing the average estimation of $7.08M by -302.92%. The company's SG&A was $101.95M, beating the average forecast of $89.87M by 13.44%. Lastly, the company's EPS was $-0.32, missing the average prediction of $0.154 by -307.95%